調査レポートカテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

Swabs Market by Application and Geography - Forecast and Analysis 2019-2023

綿棒の世界市場予測・分析：用途別

◆タイトル：Swabs Market by Application and Geography - Forecast and Analysis 2019-2023
◆商品コード：IRTNTR32171
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2019年10月
◆ページ数：141
◆資料形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥0見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥0見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥0見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

Technavio社の本調査レポートでは、綿棒の世界市場について調べ、綿棒の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、綿棒の市場規模をセグメンテーション別（用途別（医療、産業、その他）、）と地域別（グローバル）に分けて算出しました。Technavio社は綿棒の世界市場規模が2019-2023期間中に年平均8%成長すると予測しています。
・サマリー
・レポートの範囲
・綿棒の市場状況
・綿棒の市場規模
・綿棒の市場予測
・綿棒の世界環境：ファイブフォース分析
・市場セグメンテーション：用途別（医療、産業、その他）
・綿棒の顧客状況
・主要地域別市場規模：グローバル
・市場動向・成長要因・課題
・関連企業状況・企業分析
　...

Global Swabs Market: About this market
Technavio’s swabs market analysis considers sales from medical, industrial, and other applications. Our study also finds the sales of swabs in Asia, Europe, North America, and ROW. In 2018, the medical segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of infectious diseases, such as influenza, hepatitis, cholera, sepsis, and tuberculosis, will play a significant role in the medical segment to maintain its market position. Also, our global swabs market report looks at factors such as rising demand for sample collection for infectious disease diagnosis, significant demand for swab for cleaning validation in pharmaceutical industry, and increasing demand for infection control in healthcare facilities. However, limitations in standardization of swab sampling, lack of expertise, and presence of strong substitutes for environmental assessments may hamper the growth of the swabs industry over the forecast period.

Global Swabs Market: Overview
Adoption of environmental monitoring in healthcare facilities
There is an increase in the demand for pathogenic control among healthcare facilities due to the rising number of cases of hospital-borne infections. This has raised concerns among government and non-government organizations to provide guidelines on prevention and control of hospital-associated infection by adopting environmental monitoring in healthcare units. As a result, the maintenance of low microbial burden and optimum hygiene conditions have become the utmost priority of these healthcare units. The development and deployment of microbial monitoring systems by healthcare providers will boost the adoption of swabs as an applicator in various healthcare and life sciences applications. Thus, the adoption of swabs as a sampling tool in POC test kits, cleaning validation in the pharmaceutical industry, and collection devices will lead to the expansion of the global swabs market at a CAGR of almost 8% during the forecast period.

Increase in the adoption of online product ordering
The increasing adoption of advanced IT infrastructure by end-users has enabled market vendors to explore new business opportunities through the online sales channel. End-users such as diagnostic laboratories, hospitals, and clinics are increasingly adopting digital platforms such as laboratory information management systems (LIMS) for efficient resource management and meeting GLP requirements. Market vendors are concentrating on the availability of their swab products for online sales on their official websites. Thus, to meet the need of GLP practices and avail customizable delivery options, end-users are increasingly promoting the purchase of swab products through online platforms, thereby driving the sales in the global swabs market. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global swabs market during the forecast period 2019-2023, click here.

Competitive Landscape
With the presence of several major players, the global swabs market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading swabs manufacturers, that include 3M Co., AdvaCare Pharma, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Merck KGaA, PURITAN MEDICAL PRODUCTS Co. LLC, SARSTEDT AG & Co. KG, Thermo Fisher Scientific Inc., and Unilever Group.
Also, the swabs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Medical – Market size and forecast 2018-2023
• Industrial – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Advent of advanced and innovative swab collection devices
• Increasing demand for swab products as sampling tool in POC test kits
• Growing adoption of online product ordering
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• 3M Co.
• AdvaCare Pharma
• Becton, Dickinson and Co.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Merck KGaA
• PURITAN MEDICAL PRODUCTS Co. LLC
• SARSTEDT AG & Co. KG
• Thermo Fisher Scientific Inc.
• Unilever Group
PART 13: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 14: EXPLORE TECHNAVIO

 

Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Application – Market share 2018-2023 (%)
Exhibit 19: Comparison by application
Exhibit 20: Medical – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Medical – Year-over-year growth 2019-2023 (%)
Exhibit 22: Industrial – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Industrial – Year-over-year growth 2019-2023 (%)
Exhibit 24: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity

Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: M Co. – Vendor overview
Exhibit 47: M Co. – Business segments
Exhibit 48: M Co. – Organizational developments
Exhibit 49: M Co. – Geographic focus
Exhibit 50: M Co. – Segment focus
Exhibit 51: M Co. – Key offerings
Exhibit 52: AdvaCare Pharma – Vendor overview
Exhibit 53: AdvaCare Pharma – Product segments
Exhibit 54: AdvaCare Pharma – Key offerings
Exhibit 55: Becton, Dickinson and Co. – Vendor overview
Exhibit 56: Becton, Dickinson and Co. – Business segments
Exhibit 57: Becton, Dickinson and Co. – Organizational developments
Exhibit 58: Becton, Dickinson and Co. – Geographic focus
Exhibit 59: Becton, Dickinson and Co. – Segment focus
Exhibit 60: Becton, Dickinson and Co. – Key offerings
Exhibit 61: bioMérieux SA – Vendor overview
Exhibit 62: bioMérieux SA – Product segments
Exhibit 63: bioMérieux SA – Organizational developments
Exhibit 64: bioMérieux SA – Geographic focus
Exhibit 65: bioMérieux SA – Key offerings
Exhibit 66: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 67: Bio-Rad Laboratories Inc. – Business segments
Exhibit 68: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 69: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 70: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 71: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 72: Merck KGaA – Vendor overview
Exhibit 73: Merck KGaA – Business segments
Exhibit 74: Merck KGaA – Organizational developments
Exhibit 75: Merck KGaA – Geographic focus
Exhibit 76: Merck KGaA – Segment focus
Exhibit 77: Merck KGaA – Key offerings
Exhibit 78: PURITAN MEDICAL PRODUCTS Co. LLC – Vendor overview
Exhibit 79: PURITAN MEDICAL PRODUCTS Co. LLC – Product segments
Exhibit 80: PURITAN MEDICAL PRODUCTS Co. LLC – Organizational developments
Exhibit 81: PURITAN MEDICAL PRODUCTS Co. LLC – Key offerings
Exhibit 82: SARSTEDT AG & Co. KG – Vendor overview
Exhibit 83: SARSTEDT AG & Co. KG – Product segments
Exhibit 84: SARSTEDT AG & Co. KG – Organizational developments
Exhibit 85: SARSTEDT AG & Co. KG – Key offerings
Exhibit 86: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 87: Thermo Fisher Scientific Inc. – Business segments
Exhibit 88: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 89: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 90: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 91: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 92: Unilever Group – Vendor overview
Exhibit 93: Unilever Group – Business segments
Exhibit 94: Unilever Group – Organizational developments
Exhibit 95: Unilever Group – Geographic focus
Exhibit 96: Unilever Group – Segment focus
Exhibit 97: Unilever Group – Key offerings
Exhibit 98: Validation techniques employed for market sizing
Exhibit 99: Definition of market positioning of vendors



【掲載企業】

3M Co., AdvaCare Pharma, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Merck KGaA, PURITAN MEDICAL PRODUCTS Co. LLC, SARSTEDT AG & Co. KG, Thermo Fisher Scientific Inc., and Unilever Group.

★調査レポート[綿棒の世界市場予測・分析：用途別] (Swabs Market by Application and Geography - Forecast and Analysis 2019-2023 / IRTNTR32171)販売に関する免責事項
[綿棒の世界市場予測・分析：用途別] (Swabs Market by Application and Geography - Forecast and Analysis 2019-2023 / IRTNTR32171)についてEメールでお問い合わせ
◆関連調査資料◆
  • 美容レーザー・エネルギー装置の世界市場2019-2023
    IRTNTR31664 / Technavio / 2019年7月20日 / Technavio社の本調査レポートでは、美容レーザー・エネルギー装置の世界市場について調べ、美容レーザー・エネルギー装置の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、美容レーザー・エネルギー装置の市場規模をセグメンテーション別（技術別（レーザー、ライト、RF、その他）、）と地域別（アジア、ヨーロッパ、北米、その他）に分けて算出しました。Technavio社は美容レーザー・エネルギー装置の世界市場規模が2019-2023期間中に年平均11%成長すると予測しています。 ・サマリー ・レポートの範囲 ・美容レーザー・エネルギー装置の市場状況 ・美容レーザー・エネルギー装置の市場規模 ・美容レーザー・エネルギー装置の市場予測 ・美容レーザー・エネルギー装置の世界環境：ファイブフォース分析 ・市場セグメンテーション：技術別（レーザー、ライト、RF、その他） ・美容レーザー・エネルギー装置の顧客状況 ・主要地域別市場規模：アジア、ヨーロッパ、北米、その他...Global Aesthetic Lasers and Energy Devices Market: About this market Aesthetic lasers and energy devices are medical devices used for various cosmetic procedures to treat skin and body defects through minimally invasive or invasive technologies. Technavio’s aesthetic lasers and energy devices market analysis considers sales from the laser, light, RF, and others. Our analysis also considers the sales of aesthetic lasers and energy devices in Asia, Europe, North America, and ROW. In 2018, the laser segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the increasing use of laser-based aesthetic...
  • 抗菌治療法の世界市場予測・分析：用途別・地域別
    IRTNTR31420 / Technavio / 2019年6月19日 / Technavio社の本調査レポートでは、抗菌治療法の世界市場について調べ、抗菌治療法の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、抗菌治療法の市場規模をセグメンテーション別（用途別（抗ウイルス薬、抗菌、抗真菌、駆虫剤）、）と地域別（アジア、ヨーロッパ、北米、その他）に分けて算出しました。Technavio社は抗菌治療法の世界市場規模が2019-2023期間中に年平均4%成長すると予測しています。 ・サマリー ・レポートの範囲 ・抗菌治療法の市場状況 ・抗菌治療法の市場規模 ・抗菌治療法の市場予測 ・抗菌治療法の世界環境：ファイブフォース分析 ・市場セグメンテーション：用途別（抗ウイルス薬、抗菌、抗真菌、駆虫剤） ・抗菌治療法の顧客状況 ・主要地域別市場規模：アジア、ヨーロッパ、北米、その他...Global Antimicrobial Therapeutics Market: About this market Antimicrobial drugs include antibiotics, antifungals, antiprotozoal, and antivirals, which help kill microorganisms or inhibit their growth. Technavio’s antimicrobial therapeutics market analysis considers sales from applications including antiviral, antibacterial, antifungal, and antiparasitic. Our analysis also considers the sales of antimicrobial therapeutics in Asia, Europe, North America, and ROW. In 2018, the antiviral segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising incidence of viral infections, including HIV, hepatitis, and influenza, will play a significant role in the antiviral segment to maintain...
  • ブドウ球菌感染症医薬の世界市場2019-2023
    IRTNTR31241 / Technavio / 2019年4月29日 / 当調査レポートでは、ブドウ球菌感染症医薬の世界市場について調査・分析し、市場概要、市場環境、ブドウ球菌感染症医薬市場規模、製品別（βラクタム、ペプチド、キノロン、マクロライド、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・ブドウ球菌感染症医薬の世界市場概要 ・ブドウ球菌感染症医薬の世界市場環境 ・ブドウ球菌感染症医薬の世界市場動向 ・ブドウ球菌感染症医薬の世界市場規模 ・ブドウ球菌感染症医薬の世界市場：業界構造分析 ・ブドウ球菌感染症医薬の世界市場：製品別（βラクタム、ペプチド、キノロン、マクロライド、その他） ・ブドウ球菌感染症医薬の世界市場：地域別市場規模・分析...About this market Regulatory agencies are granting special drugs designations for the development of drugs for the treatment of infectious diseases, including those used for the treatment of staphylococcal infection. Special drug designations offer incentives for the development of new drugs for the treatment which is encouraging more and more manufacturers to invest in the development of drugs, which in turn is driving the market. Technavio’ s analysts have predicted that the staphylococcal infection drugs market will register a CAGR of nearly 3% by 2023. Market Overview Increasing incidence of staphylococcal infections The emergence of antibiotics resistant strains has led...
  • 高速液体クロマトグラフィー（HPLC）の世界市場2019-2023
    IRTNTR30786 / Technavio / 2019年2月23日 / 当調査レポートでは、高速液体クロマトグラフィー（HPLC）の世界市場について調査・分析し、市場概要、市場環境、高速液体クロマトグラフィー（HPLC）市場規模、流通経路別（オンライン、オフライン）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・高速液体クロマトグラフィー（HPLC）の世界市場概要 ・高速液体クロマトグラフィー（HPLC）の世界市場環境 ・高速液体クロマトグラフィー（HPLC）の世界市場動向 ・高速液体クロマトグラフィー（HPLC）の世界市場規模 ・高速液体クロマトグラフィー（HPLC）の世界市場：業界構造分析 ・高速液体クロマトグラフィー（HPLC）の世界市場：流通経路別（オンライン、オフライン） ・高速液体クロマトグラフィー（HPLC）の世界市場：地域別市場規模・分析...About this market Several private and government stakeholders are investing heavily in R&D activities in the healthcare sector. This is mainly to launch products with innovative new technologies in the field of HPLC and to increase the potential of the healthcare industry. Pharmaceutical companies are opting for HPLC for sample testing and analysis. This technique is used to identify potential ingredients for manufacturing drugs. The increasing investments are enabling vendors to develop and manufacture more innovative HPLC products. This is driving the demand among end-users and leading to the rapid growth of the global high-performance liquid chromatography (HPLC) market. Technavio’s...
  • 感染症治療薬の世界市場2019-2023
    IRTNTR30461 / Technavio / 2018年12月12日 / 当調査レポートでは、感染症治療薬の世界市場について調査・分析し、市場概要、市場環境、感染症治療薬市場規模、種類別（抗ウイルス剤、抗菌剤、抗真菌剤、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・感染症治療薬の世界市場概要 ・感染症治療薬の世界市場環境 ・感染症治療薬の世界市場動向 ・感染症治療薬の世界市場規模 ・感染症治療薬の世界市場：業界構造分析 ・感染症治療薬の世界市場：種類別（抗ウイルス剤、抗菌剤、抗真菌剤、その他） ・感染症治療薬の世界市場：地域別市場規模・分析...About this market Development of novel drugs to drive growth in the market. There has been an increase in the R&D of novel drugs for the treatment of infectious diseases. Technavio’s analysts have predicted that the infectious disease therapeutics market will register a CAGR of over 4% by 2023. Market Overview Increasing prevalence of infectious diseases There has been an increase in the prevalence of infectious diseases due to climate variability. This is expected to be a major driver of the market growth during the forecast period. Availability of counterfeit drugs Counterfeit drugs are available in low-income and developing countries....
  • 出血性脳卒中の世界市場2019-2023
    IRTNTR30243 / Technavio / 2018年11月21日 / 当調査レポートでは、出血性脳卒中の世界市場について調査・分析し、市場概要、市場環境、出血性脳卒中市場規模、製品別（抗高血圧症治療薬、抗凝固剤、利尿剤、抗痙攣剤）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・出血性脳卒中の世界市場概要 ・出血性脳卒中の世界市場環境 ・出血性脳卒中の世界市場動向 ・出血性脳卒中の世界市場規模 ・出血性脳卒中の世界市場：業界構造分析 ・出血性脳卒中の世界市場：製品別（抗高血圧症治療薬、抗凝固剤、利尿剤、抗痙攣剤） ・出血性脳卒中の世界市場：地域別市場規模・分析...About this market The improved diagnostic modalities for hemorrhagic stroke recovery to help market grow. For the appropriate management of hemorrhagic stroke, an adequate understanding of parenchymal hemorrhage is crucial. Since intracerebral hemorrhage is an acute clinical manifestation of the underlying cerebral small vessel diseases (cSVDs), it is essential to use improved diagnostic modalities such as MRI markers to monitor the risk stratification. Technavio’s analysts have predicted that the hemorrhagic stroke treatment market will register a CAGR of almost 4% by 2023. Market Overview Rising incidence in aging population Increasing age is a major risk for several conditions, including intracerebral...
  • TNF阻害剤の世界市場2019-2023
    IRTNTR30008 / Technavio / 2018年10月15日 / TNFは、マクロファージによって産生され、様々な自己免疫疾患の原因とされている全身性炎症を引き起こす細胞内シグナル伝達サイトカインです。TNF阻害剤は、これらの疾患によって引き起こされる炎症を沈静化させる薬剤です。TNF阻害剤の世界市場は、2019～2023年の間、年平均成長率9.58%で成長すると予測されています。 主な分析対象企業は、AbbVie、Amgen、Johnson & Johnson、Novartis、Pfizer、UCBなどです。 当調査レポートでは、TNF阻害剤の世界市場について調査・分析し、市場概要、市場環境、TNF阻害剤市場規模、適応症別（RA、乾癬、IBD、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・TNF阻害剤の世界市場概要 ・TNF阻害剤の世界市場環境 ・TNF阻害剤の世界市場動向...About Tumor Necrosis Factor (TNF) TNF is a cell signaling cytokine that is secreted by macrophages and plays a role in systemic inflammation, which is known to be the cause of various autoimmune diseases. TNF inhibitors are drugs that reverse the damage caused by these diseases. Technavio’s analysts forecast the Global TNF Inhibitors Market to grow at a CAGR of 9.58% during the period 2019-2023. [Covered in this report] The report covers the present scenario and the growth prospects of the TNF inhibitors market. To calculate the market size, the report considers the revenue generated from the application of TNF...
  • 骨成長刺激装置の世界市場2019-2023
    IRTNTR30058 / Technavio / 2018年10月31日 / 骨成長刺激装置は、外傷や骨折を治癒するために使用されます。該当する身体部分に少量の電流を流すことによって、骨の治癒過程を強化します。骨成長刺激装置の世界市場は、2019～2023年の間に、年平均成長率5.30％で成長すると予測されています。 主な分析対象企業は、Bioventus、DJO Global、Orthofix、Zimmer Biometなどです。 当調査レポートでは、骨成長刺激装置の世界市場について調査・分析し、市場概要、市場環境、骨成長刺激装置市場規模、製品別（外部、内部）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・骨成長刺激装置の世界市場概要 ・骨成長刺激装置の世界市場環境 ・骨成長刺激装置の世界市場動向...About Bone Growth Stimulation Devices Bone growth stimulation devices are used to heal trauma injuries and fractures. They help enhance the bone healing process by delivering low amounts of electric current to the affected body part. Technavio’s analysts forecast the Global Bone Growth Stimulation Devices Market to grow at a CAGR of 5.30% during the period 2019-2023. [Covered in this report] The report covers the present scenario and the growth prospects of the bone growth stimulation devices market. To calculate the market size, the report considers the revenue generated by the sale of bone growth stimulation devices across the globe....
  • イヌの関節炎治療の世界市場2019-2023
    IRTNTR30043 / Technavio / 2018年10月31日 / 関節炎はイヌが抱える最も一般的な変性疾患です。骨や関節に影響を及ぼし、運動や動きに支障をきたします。イヌの関節炎治療の世界市場は、2019～2023年の間に、年平均成長率4.71％で成長すると予測されています。 主な分析対象企業は、Bayer、Boehringer Ingelheim、Eli Lilly、Vetoquinol、Zoetisなどです。 当調査レポートでは、イヌの関節炎治療の世界市場について調査・分析し、市場概要、市場環境、イヌの関節炎治療市場規模、製品別（NSAID、オピオイド、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・イヌの関節炎治療の世界市場概要 ・イヌの関節炎治療の世界市場環境 ・イヌの関節炎治療の世界市場動向...About Canine Arthritis Arthritis is the most common degenerative disease in canines. It affects the bones and joints and causes difficulties with mobility. Technavio’s analysts forecast the Global Canine Arthritis Treatment Market to grow at a CAGR of 4.71% during the period 2019-2023. [Covered in this report] The report covers the present scenario and the growth prospects of the canine arthritis treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of canine arthritis across the globe. The market is divided into the following segments based on geography: •...
  • 双極性障害治療の世界市場2019-2023
    IRTNTR30013 / Technavio / 2018年10月31日 / 双極性障害は、気分、エネルギー、および活動レベルの極端な変化を引き起こす躁うつ病としても知られています。気分変動の上昇は、躁病または軽躁病と呼ばれ、精神病の重症度および有無に基づいて異なります。双極性障害は、双極性I、双極性II、および循環性貧血に分類される長期持続性の疾患です。この疾患は、定期的な治療で管理できます。不眠、体重増加・減少、行動変化、および精神不安定は、双極性障害で見られる症状の一部です。双極性障害治療の世界市場は、2019～2023年の間に、年平均成長率2.38%で成長すると予測されています。 主な分析対象企業は、Allergan、AstraZeneca、Eli Lilly、GlaxoSmithKline、Johnson & Johnsonなどです。 当調査レポートでは、双極性障害治療の世界市場について調査・分析し、市場概要、市場環境、双極性障害治療市場規模、製品別（抗精神病薬、抗けいれん薬、従来の精神安定薬、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・双極性障害治療の世界市場概要 ・双極性障害治療の世界市場環境...About Bipolar Disorder Bipolar disorder is also known as manic depression that causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar I, bipolar II, and cyclothymia. This condition can be managed with a regular treatment. Insomnia, weight gain or loss, behavioral changes, and psychological imbalances are some of the symptoms witnessed in individuals with bipolar disorder. Technavio’s analysts forecast the Global Bipolar Disorder Therapeutics Market to grow at a CAGR...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆